Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisisNATURE COMMUNICATIONSIF15.72023-09-016OAAI
MULTIMODAL GLIOMA IMMUNOTHERAPY COMBINING TLR9-TARGETED STAT3 ANTISENSE OLIGODEOXYNUCLEOTIDES WITH PD1-SPECIFIC IMMUNE CHECKPOINT BLOCKADEJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
ACTIVATION OF STAT3 SIGNALING IS ASSOCIATED WITH RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS IN PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC)JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
STAT3 SIGNALING AS A CHECKPOINT FOR TLR9-DRIVEN EPIGENETIC REPROGRAMMING OF ACUTE MYELOID LEUKEMIA INTO ANTIGEN-PRESENTING CELLSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinomaJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-03-0929OAAI
STAT3 INHIBITION IN ACUTE MYELOID LEUKEMIA CELLS ALLOWS FOR TLR9-DRIVEN DIFFERENTIATION TO IMMUNOGENIC MONOCYTIC CELLS AND INDUCTION OF T-CELL MEDIATED IMMUNE RESPONSESJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-12-100PREAI
INVESTIGATING MYELOID DERIVED SUPPRESSOR CELLS (MDSCS) AND OLIGONUCLEOTIDE BASED TARGETING OF STAT3 IN RENAL CELL CARCINOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-11-090PREAI
STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate CancersCLINICAL CANCER RESEARCHIF10.22018-12-0372OAAI
Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase InhibitorsCLINICAL CANCER RESEARCHIF10.22015-11-3061OAAI
TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer PatientsCLINICAL CANCER RESEARCHIF10.22015-08-13164OAAI
Intracellular processing of immunostimulatory CpG-siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escapeJOURNAL OF CONTROLLED RELEASEIF11.52013-09-0151OAAI